SLC7A11 and cancer: MLL4 is often mutated in human cancers, and its deficiency can result in decreased expression of pro-ferroptosis genes, including ALOX12, ALOX12B, and ALOXE3, as well as increased expression of anti-ferroptosis proteins such as SLC7A11 and GPX4 [30].